Personalized cancer treatment study based on your response
Part of Cancer clinical trials.
This study uses a personalized cancer treatment plan and looks at how well it works and side effects. You may be able to join if you (or your parent/guardian, if needed) are willing to consent to the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing to sign informed consent, or have a parent/guardian sign it
- If you are a minor, you must be willing to give assent (your agreement to participate)
- You should be able to understand and decide about joining the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying a way to help guide individualized cancer treatment using your existing medical information. If you receive cancer care at the specific study sites, you may be able to enroll.
This early-phase study tests whether a personalized cancer treatment plan based on your tumor’s test results can help people with aggressive cancers that are hard to treat. It may be an option if standard treatments didn’t work, aren’t possible for you, or you have few treatment choices.
This study collects evidence on personalized (“targeted”) cancer treatments for adults with rare cancers or rare tumor changes. If you may qualify, it may help make these treatments more widely available in the future by studying how well they work and how patients feel.
This Phase 2 study uses a team review of your tumor’s gene test results to help match you with treatments you may benefit from. It’s designed for people whose tumor has specific gene changes that suggest sensitivity to available medicines or may involve inherited (germline) risk.
This trial tests a personalized vaccine made from your cancer's unique markers. The goal is to train your immune system to fight the cancer, potentially slowing it down when other options have run out.
This study tests whether choosing cancer treatments based on the unique genetic changes in your tumor can help people with advanced cancer live longer. You would receive FDA-approved drugs that match your tumor's specific markers.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.